News
Zacks Investment Research on MSN1d
Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain?Thermo Fisher Scientific TMO has unveiled its latest innovation, the spectral-enabled Invitrogen Attune Xenith Flow Cytometer. The solution allows immunology and immuno-oncology researchers to ...
Thermo Fisher Scientific, a $151.8 billion science giant, is struggling on the stock front despite its cutting-edge ...
Barchart on MSN1d
Is Thermo Fisher Scientific Stock Underperforming the Nasdaq?With a market cap of $151.8 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, offering ...
Thermo Fisher Scientific stock may remain sluggish through November. What's behind the weakness and is TMO a buy now?
Thermo Fisher has unleashed its next-generation TruNarc Delta and Tau Handheld Narcotics Analyzers to help law enforcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback